UC Irvine’s Institute for Memory Impairments and Neurological Disorders raised some $300,000 at its A December to Remember Gala on Dec. 5, 2020. The event took place virtually for the very…
Read More
UCI MIND Clinical Research Director David Sultzer, MD was featured on CBS2/KCAL9 to discuss Tony Bennett’s recent Alzheimer’s disease diagnosis and how music and memory are intertwined. Watch the video…
Read More
MarketWatch – Nov. 30, 2020 The University of California, Irvine’s Institute for Memory Impairments and Neurological Disorders (UCI MIND) has studied elderly individuals as part of its “90+ Study” since 2003,…
Read More
The University of California, Irvine is undertaking a five-year, multi-million dollar project to expand research on Alzheimer’s disease in people with Down syndrome. The National Institute of Health awarded a…
Read More
Will Biogen’s aducanumab become the first drug approved to slow progression of Alzheimer’s disease? UCI MIND faculty member and chair of UCI Statistics, Dr. Daniel Gillen, and other experts comment…
Read More
The post New insights from study of people age 90 and above appeared first on UCI MIND.
Read More
Contributed by UCI News: UCI’s Center for Neural Circuit Mapping is redrawing our understanding of mechanisms underlying several common disorders by Ian Anzlowar, UCI | November 18, 2020 Thanks to…
Read More
For the first time in the event’s decade-long history, the University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND)’s A December to Remember gala will raise…
Read More
“Our findings suggest that older individuals experiencing cognitive decline have relatively stable ideological preferences, but these preferences lose their connection to political policy details. Future studies conducted during an election…
Read More
FLASH radiation therapy, also called FLASH-RT, can eliminate the debilitating side effects associated with traditional radiation therapy by delivering the same dose in tenths of seconds, and can remove tumors,…
Read More